Questions for Future Research
Q: Because healthy oligodendrocyte progenitor cells are important for the child’s developing brain, how could further characterization of NG2 isoforms help prevent drugs from damaging those beneficial cells?
Q: Could NG2-binding peptides cross the blood-brain barrier to deliver anti-cancer therapies precisely to tumor sites?
Source: “The Role of NG2 Proteoglycan in Glioma.” S. Yadavilli, E.I. Hwang, R. J. Packer, and J. Nazarian. Published by Translational Oncology on February 2016.
You might also like
LATEST TWEETS FROM INNOVATION DISTRICT
Vote NOW to help research led by @ChildrensNatl that trains the immune system to tackle tough-to-treat tumors. Our #novel T-cells are infused in just a few minutes & are less toxic than chemo. Look for our Dr. Bear logo and VOTE! #STATMadness http://spr.ly/60171aklD
We have made it to the semi-finals of #STATMadness and we are down to our #pHab4!
Congratulations to @Texas_Heart, @fredhutch, @ChildrensNatl, and @kochinstitute for making it this far!
But the works not done — more voting is needed! http://buff.ly/33Pxgk5